The loss of PER1 may influence OSCC progression via the AKT/mTOR signaling pathway, while PER1 modulates cell proliferation through glycolysis regulation and the PI3K/AKT pathway, positioning it as a tumor suppressor [77]. The gene discussed is AKT1; the disease is neoplasm.